Pati Church
Nurse Practitioner · Ann Arbor, MINPI 1225194038
Payments from drug & device makers
Across 171 payments — averaging $20.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$334
- Rochester Medical Corporation$328
- Johnson & Johnson$268
- AbbVie$224
- 180 Medical, Inc.$182
- Sumitomo Pharma America, Inc.$173
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,31494%
- Education$2286%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 17 | $334 |
| Rochester Medical Corporation | 15 | $328 |
| Johnson & Johnson | 9 | $268 |
| AbbVie(2 entities) | 12 | $224 |
| 180 Medical, Inc. | 8 | $182 |
| Sumitomo Pharma America, Inc. | 9 | $173 |
| Coloplast | 8 | $168 |
| Olympus America Inc. | 9 | $166 |
| Myovant Sciences Inc. | 5 | $129 |
| Tolmar Pharmaceuticals, Inc. | 11 | $121 |
| Sun Pharmaceutical Industries Inc. | 5 | $118 |
| Tolmar, Inc. | 5 | $106 |
| Urovant Sciences Inc | 6 | $105 |
| Merck | 4 | $97 |
| Seagen Inc. | 1 | $85 |
| Halozyme Inc | 4 | $82 |
| Axonics, Inc. | 4 | $80 |
| Pfizer | 4 | $69 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $59 |
| Progenics Pharmaceuticals, Inc. | 3 | $58 |
| Endo Pharmaceuticals Inc. | 3 | $55 |
| Procept Biorobotics Corporation | 3 | $53 |
| Urogen Pharma, Inc. | 2 | $50 |
| Clarus Therapeutics Inc. | 2 | $46 |
| Antares Pharma, Inc. | 3 | $45 |
| Blue Earth Diagnostics | 2 | $43 |
| Laborie Medical Technologies Corp. | 2 | $36 |
| Novartis | 1 | $32 |
| Avyxa Pharma, LLC | 1 | $30 |
| Teleflex LLC | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $22 |
| Vertex | 1 | $21 |
| Endo USA, Inc. | 1 | $20 |
| Immunitybio, Inc. | 1 | $19 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Bayer | 1 | $17 |
| Dentsply IH AB | 1 | $16 |
| Photocure Inc | 1 | $15 |
| Dentsply IH Inc. | 1 | $15 |
| Medtronic | 1 | $14 |
How this compares
$3,541 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 59 | $36,327 |
| GemtesaVibegron | 28 | $29,736 |
| Mirabegron ErMirabegron | 22 | $12,564 |
| Tamsulosin Hcl | 203 | $3,762 |
| Oxybutynin Chloride ErOxybutynin Chloride | 43 | $1,732 |
| Tolterodine Tartrate ErTolterodine Tartrate | 16 | $1,545 |
| Finasteride | 71 | $1,489 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 67 | $743 |
| Solifenacin Succinate | 17 | $619 |
| Ciprofloxacin Hcl | 51 | $264 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 103 | $235 |
| Cephalexin | 31 | $177 |
| Oxybutynin Chloride | 12 | $124 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $121 |
| Fluconazole | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $334 | $36,32759 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $173 | $29,73628 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Ann Arbor
- Elizabeth KirshnerAnn Arbor$119K
- Susanne Mc DevittAnn Arbor$23K
- Jennifer DubnickiAnn Arbor$19K
- Ashley KliszAnn Arbor$19K
- Caitlin BoyakAnn Arbor$14K
- Rebecca PriebeAnn Arbor$13K
- Tara WilliamsonAnn Arbor$13K
- Kimberly DimariaAnn Arbor$12K
- Christopher NaismithAnn Arbor$10K
- Diane BohnAnn Arbor$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.